English   español  

Browsing by Author rp08212

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 19 of 19
RightsPreviewIssue DateTitleAuthor(s)Type
closedAccessaccesoRestringido.pdf.jpg2008Aplidin, a marine organism-derived compound with potent antimyeloma activity in vitro and in vivoMitsiades, C. S.; Ocio, Enrique M.  ; Pandiella, Atanasio  ; Maiso, Patricia; Gajate, Consuelo; Garayoa, Mercedes  ; Vilanova, David; Montero, Juan Carlos ; Mollinedo, Faustino ; San Miguel, Jesús F. Artículo
openAccessCD20 positive.pdf.jpg2012CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotypePaíno, Teresa ; Ocio, Enrique M.  ; Paiva, Bruno; San-Segundo, Laura; Garayoa, Mercedes  ; Gutiérrez, Norma Carmen; Sarasquete, María Eugenia; Pandiella, Atanasio  ; Orfao, Alberto  ; San Miguel, Jesús F. Artículo
openAccessDasatinib as.pdf.jpg2012Dasatinib as a bone-modifying agent: Anabolic and anti-resorptive effectsGarcía-Gómez, Antonio; Ocio, Enrique M.  ; Crusoe, Edvan; Santamaría, Carlos; Hernández-Campo, Pilar M.; Blanco, Juan F.; Sánchez-Guijo, Fermín M.; Hernández, M. Teresa ; Briñón, Jesús G.; Pandiella, Atanasio  ; San Miguel, Jesús F. ; Garayoa, Mercedes  Artículo
openAccess10.3324-haematol.2009.015495.pdf.jpg1-May-2010In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myelomaOcio, Enrique M.  ; Vilanova, David; Maiso, Patricia; Crusoe, Edvan; Fernández-Lázaro, Diego; Garayoa, Mercedes  ; San-Segundo, Laura; Hernández, M. Teresa ; San Miguel, Jesús F. Artículo
closedAccessaccesoRestringido.pdf.jpg2015In vivo murine model of acquired resistance in myeloma reveals differential mechanisms for lenalidomide and pomalidomide in combination with dexamethasoneOcio, Enrique M.  ; Fernández-Lázaro, Diego; San-Segundo, Laura; López-Corral, L.; Corchete, Luis A.; Gutiérrez, Norma Carmen; Garayoa, Mercedes  ; Paíno, Teresa ; García-Gómez, Antonio; Delgado, Manuel; Montero, Juan Carlos ; Díaz-Rodríguez, Elena ; Mateos, Maria Victoria; Pandiella, Atanasio  ; San Miguel, Jesús F. Artículo
closedAccessaccesoRestringido.pdf.jpg2009Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donorsGenomic profile of multiple myeloma MSCsGarayoa, Mercedes  ; García, Juan L.  ; Santamaría, Carlos; García-Gómez, Antonio; Blanco, Juan F.; Pandiella, Atanasio  ; Hernández, Jesús M.  ; Sánchez-Guijo, Fermín M.; Cañizo, María Consuelo del; Gutiérrez, Norma Carmen; San Miguel, Jesús F. Artículo
openAccessMultipleMyelomaCellLines.PDF.jpg2014Phenotypic, genomic and functional characterization reveals no differences between CD138++ and CD138low subpopulations in multiple myeloma cell linesPaíno, Teresa ; Sarasquete, María Eugenia; Paiva, Bruno; Krzemiński, Patryk; San-Segundo, Laura; Corchete, Luis A.; Redondo, Alba; Garayoa, Mercedes  ; García-Sanz, Ramón; Gutiérrez, Norma Carmen; Ocio, Enrique M.  ; San Miguel, Jesús F. Artículo
closedAccessaccesoRestringido.pdf.jpg2014Preclinical activity of the oral proteasome inhibitor mln9708 in myeloma bone diseaseGarcía-Gómez, Antonio; Ocio, Enrique M.  ; Blanco, Juan F.; Hernández-Iglesias, Teresa; Fraile, Susana ; San Miguel, Jesús F. ; Garayoa, Mercedes  Artículo
openAccesspreclirepai.pdf.jpg2017Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repairLópez-Iglesias, Ana-Alicia; Herrero, Ana B.; Chesi, Marta; San-Segundo, Laura; González-Méndez, Lorena; Hernández-García, Susana; Misiewicz-Krzeminska, Irena; Quwaider, Dalia; Martín-Sánchez, Montserrat; Primo, Daniel; Paíno, Teresa ; Bergsagel, P. Leif; Mehrling, Thomas; González, Marcos  ; San Miguel, Jesús F. ; Mateos, Maria Victoria; Gutiérrez, Norma Carmen; Garayoa, Mercedes  ; Ocio, Enrique M.  Artículo
closedAccessaccesoRestringido.pdf.jpg2013RAF265, a dual BRAF and VEGFR2 inhibitor, prevents osteoclast formation and resorption. Therapeutic implicationsGarcía-Gómez, Antonio; Ocio, Enrique M.  ; Pandiella, Atanasio  ; San Miguel, Jesús F. ; Garayoa, Mercedes  Artículo
openAccessGarcia Bernal et al.pdf.jpgFeb-2013Sphingosine-1-phosphate activates chemokine-promoted myeloma cell adhesion and migration involving α4β1 integrin functionGarcía-Bernal, David ; Redondo-Muñoz, Javier; Dios-Esponera, Ana ; Chèvre, Raphaël; Bailón, Elvira ; Garayoa, Mercedes  ; Arellano-Sánchez, Nohemí ; Gutiérrez, Norma C.; Hidalgo, Andrés; García-Pardo, Angeles ; Teixidó, Joaquín Artículo
openAccessZaBDeFinalversion.pdf.jpg2017Synergistic DNA-damaging effect in multiple myeloma with the combination of zalypsis, bor tezomib and dexamethasoneLópez-Iglesias, Ana-Alicia; González-Méndez, Lorena; San-Segundo, Laura; Herrero, Ana B.; Hernández-García, Susana; Martín-Sánchez, Montserrat; Gutiérrez, Norma Carmen; Paíno, Teresa ; Avilés Marín, Pablo; Mateos, Maria Victoria; San Miguel, Jesús F. ; Garayoa, Mercedes  ; Ocio, Enrique M.  Artículo
openAccessThe effect of the proteasome.pdf.jpg2008The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotypeColado, Enrique; Álvarez-Fernández, Stela ; Maiso, Patricia; Martín, Jesús; Vidriales, Maria Belén; Garayoa, Mercedes  ; Ocio, Enrique M.  ; Montero, Juan Carlos ; Pandiella, Atanasio  ; San Miguel, Jesús F. Artículo
openAccessepoxyketone-based.pdf.jpg2013The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effectsGarcía-Gómez, Antonio; Ocio, Enrique M.  ; Blanco, Juan F.; Pandiella, Atanasio  ; San Miguel, Jesús F. ; Garayoa, Mercedes  ; Weilbaecher, K. N.Artículo
closedAccessaccesoRestringido.pdf.jpg2008The insulin-like growth factor-I receptor inhibitor NVP-AEW541 provokes cell cycle arrest and apoptosis in multiple myeloma cellsMaiso, Patricia; Ocio, Enrique M.  ; Garayoa, Mercedes  ; Montero, Juan Carlos ; Pandiella, Atanasio  ; San Miguel, Jesús F. Artículo
openAccesspanpimcare.pdf.jpg2017The novel pan-PIM kinase inhibitor, PIM447, displays dual antimyeloma and bone-protective effects, and potently synergizes with current standards of carePaíno, Teresa ; García-Gómez, Antonio; González-Méndez, Lorena; San-Segundo, Laura; Hernández-García, Susana; López-Iglesias, Ana-Alicia; Algarín, Esperanza M.; Martín-Sánchez, Montserrat; Corbacho-González, David; Ortiz-de-Solorzano, Carlos; Corchete, Luis A.; Gutiérrez, Norma Carmen; Mateos, Maria Victoria; Garayoa, Mercedes  ; Ocio, Enrique M.  Artículo
closedAccessaccesoRestringido.pdf.jpg2009The synergy of panobinostat plus doxorubicin in acute myeloid leukemia suggests a role for HDAC inhibitors in the control of DNA repairSynergy of panobinostat and doxorubicin in AMLMaiso, Patricia; Colado, Enrique; Ocio, Enrique M.  ; Garayoa, Mercedes  ; Pandiella, Atanasio  ; San Miguel, Jesús F. Artículo
openAccessmyelomabonedisease.pdf.jpg2014Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone diseaseGarcía-Gómez, Antonio; De Las Rivas, Javier ; Ocio, Enrique M.  ; Díaz-Rodríguez, Elena ; Montero, Juan Carlos ; Martín-Sánchez, Montserrat; Blanco, Juan F.; Sánchez-Guijo, Fermín M.; Pandiella, Atanasio  ; San Miguel, Jesús F. ; Garayoa, Mercedes  Artículo
closedAccessaccesoRestringido.pdf.jpg2012Transcriptomic rationale for the synergy observed with dasatinib + bortezomib + dexamethasone in multiple myelomaQueiroz Crusoe, Edvan de; Maiso, Patricia; Fernández-Lázaro, Diego; San-Segundo, Laura; Garayoa, Mercedes  ; García-Gómez, Antonio; Gutiérrez, Norma Carmen; Delgado, Manuel; Colado, Enrique; Ocio, Enrique M.  Artículo